Ubs Group Ag Uro Gen Pharma Ltd. Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Ubs Group Ag holds 922,698 shares of URGN stock, worth $9.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

922,698

Previous 45,775 1915.72%

Holding current value

$9.3 Million

Previous $581,000 1591.22%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$10.52 - $13.11 $9.23 Million - $11.5 Million	876,923 Added 1915.72%	922,698 $9.83 Million
Q3 2024 Nov 14, 2024	BUY	$12.7 - $17.92 $430,377 - $607,272	33,888 Added 285.08%	45,775 $581,000
Q2 2024 Aug 13, 2024	SELL	$12.72 - $19.2 $394,065 - $594,816	-30,980 Reduced 72.27%	11,887 $199,000
Q1 2024 May 13, 2024	BUY	$13.81 - $19.33 $245,790 - $344,035	17,798 Added 71.0%	42,867 $643,000
Q4 2023 Feb 09, 2024	BUY	$10.87 - $15.93 $63,589 - $93,190	5,850 Added 30.44%	25,069 $376,000
Q3 2023 Nov 09, 2023	BUY	$8.84 - $22.64 $45,181 - $115,713	5,111 Added 36.23%	19,219 $269,000
Q2 2023 Aug 11, 2023	BUY	$8.75 - $14.29 $123,445 - $201,603	14,108 New	14,108 $146,000
Q4 2022 Feb 08, 2023	SELL	$7.55 - $11.96 $157,900 - $250,131	-20,914 Reduced 47.98%	22,675 $201,000
Q3 2022 Nov 10, 2022	BUY	$7.21 - $9.41 $127,753 - $166,735	17,719 Added 68.49%	43,589 $363,000
Q2 2022 Aug 10, 2022	SELL	$5.12 - $8.74 $145,720 - $248,749	-28,461 Reduced 52.38%	25,870 $212,000
Q1 2022 May 16, 2022	BUY	$5.92 - $9.73 $39,516 - $64,947	6,675 Added 14.01%	54,331 $473,000
Q4 2021 Feb 14, 2022	BUY	$9.03 - $19.13 $418,495 - $886,579	46,345 Added 3535.09%	47,656 $453,000
Q3 2021 Nov 15, 2021	BUY	$14.31 - $18.39 $5,881 - $7,558	411 Added 45.67%	1,311 $22,000
Q2 2021 Aug 13, 2021	SELL	$15.2 - $20.94 $100,654 - $138,664	-6,622 Reduced 88.04%	900 $14,000
Q1 2021 May 12, 2021	SELL	$17.99 - $26.96 $79,227 - $118,731	-4,404 Reduced 36.93%	7,522 $147,000
Q4 2020 Feb 11, 2021	BUY	$17.54 - $25.43 $164,612 - $238,660	9,385 Added 369.34%	11,926 $215,000
Q3 2020 Nov 12, 2020	SELL	$18.81 - $26.42 $123,393 - $173,315	-6,560 Reduced 72.08%	2,541 $49,000
Q2 2020 Jul 31, 2020	SELL	$16.5 - $29.7 $38,923 - $70,062	-2,359 Reduced 20.58%	9,101 $237,000
Q1 2020 May 01, 2020	SELL	$13.68 - $34.6 $142,272 - $359,840	-10,400 Reduced 47.58%	11,460 $204,000
Q4 2019 Feb 14, 2020	BUY	$21.11 - $34.86 $166,051 - $274,208	7,866 Added 56.21%	21,860 $730,000
Q3 2019 Nov 14, 2019	BUY	$23.83 - $36.44 $251,049 - $383,895	10,535 Added 304.57%	13,994 $334,000
Q2 2019 Aug 14, 2019	BUY	$32.75 - $40.35 $23,219 - $28,608	709 Added 25.78%	3,459 $124,000
Q1 2019 May 14, 2019	SELL	$35.47 - $54.55 $55,794 - $85,807	-1,573 Reduced 36.39%	2,750 $102,000
Q4 2018 Feb 14, 2019	BUY	$38.35 - $50.39 $41,149 - $54,068	1,073 Added 33.02%	4,323 $186,000
Q3 2018 Nov 14, 2018	SELL	$41.65 - $51.7 $91,963 - $114,153	-2,208 Reduced 40.45%	3,250 $154,000
Q2 2018 Aug 14, 2018	BUY	$48.35 - $65.33 $89,302 - $120,664	1,847 Added 51.15%	5,458 $272,000
Q1 2018 May 15, 2018	BUY	$38.64 - $57.54 $33,423 - $49,772	865 Added 31.5%	3,611 $180,000
Q4 2017 Feb 14, 2018	BUY	$27.28 - $43.26 $47,630 - $75,531	1,746 Added 174.6%	2,746 $102,000
Q3 2017 Nov 14, 2017	BUY	$17.15 - $32.72 $10,753 - $20,515	627 Added 168.1%	1,000 $32,000
Q2 2017 Aug 14, 2017	BUY	N/A	373	373 $7,000

Others Institutions Holding URGN

# of Institutions

137

Shares Held

36.2M

Call Options Held

57.7K

Put Options Held

9.8K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $229M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account